IBDEI219 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34064,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,34065,0)
 ;;=N06.2^^154^1722^36
 ;;^UTILITY(U,$J,358.3,34065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34065,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse membranous glomerulonephritis
 ;;^UTILITY(U,$J,358.3,34065,1,4,0)
 ;;=4^N06.2
 ;;^UTILITY(U,$J,358.3,34065,2)
 ;;=^5015551
 ;;^UTILITY(U,$J,358.3,34066,0)
 ;;=N06.3^^154^1722^37
 ;;^UTILITY(U,$J,358.3,34066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34066,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangial prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,34066,1,4,0)
 ;;=4^N06.3
 ;;^UTILITY(U,$J,358.3,34066,2)
 ;;=^5015552
 ;;^UTILITY(U,$J,358.3,34067,0)
 ;;=N06.4^^154^1722^35
 ;;^UTILITY(U,$J,358.3,34067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34067,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse endocaplry prolif glomrlneph
 ;;^UTILITY(U,$J,358.3,34067,1,4,0)
 ;;=4^N06.4
 ;;^UTILITY(U,$J,358.3,34067,2)
 ;;=^5015553
 ;;^UTILITY(U,$J,358.3,34068,0)
 ;;=N06.5^^154^1722^38
 ;;^UTILITY(U,$J,358.3,34068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34068,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse mesangiocapillary glomrlneph
 ;;^UTILITY(U,$J,358.3,34068,1,4,0)
 ;;=4^N06.5
 ;;^UTILITY(U,$J,358.3,34068,2)
 ;;=^5015554
 ;;^UTILITY(U,$J,358.3,34069,0)
 ;;=N06.6^^154^1722^33
 ;;^UTILITY(U,$J,358.3,34069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34069,1,3,0)
 ;;=3^Isolated proteinuria w/ dense deposit disease
 ;;^UTILITY(U,$J,358.3,34069,1,4,0)
 ;;=4^N06.6
 ;;^UTILITY(U,$J,358.3,34069,2)
 ;;=^5015555
 ;;^UTILITY(U,$J,358.3,34070,0)
 ;;=N06.7^^154^1722^34
 ;;^UTILITY(U,$J,358.3,34070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34070,1,3,0)
 ;;=3^Isolated proteinuria w/ diffuse crescentic glomerulonephritis
 ;;^UTILITY(U,$J,358.3,34070,1,4,0)
 ;;=4^N06.7
 ;;^UTILITY(U,$J,358.3,34070,2)
 ;;=^5015556
 ;;^UTILITY(U,$J,358.3,34071,0)
 ;;=N06.8^^154^1722^41
 ;;^UTILITY(U,$J,358.3,34071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34071,1,3,0)
 ;;=3^Isolated proteinuria w/ other morphologic lesion
 ;;^UTILITY(U,$J,358.3,34071,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,34071,2)
 ;;=^5015557
 ;;^UTILITY(U,$J,358.3,34072,0)
 ;;=N06.9^^154^1722^42
 ;;^UTILITY(U,$J,358.3,34072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34072,1,3,0)
 ;;=3^Isolated proteinuria w/ unspecified morphologic lesion
 ;;^UTILITY(U,$J,358.3,34072,1,4,0)
 ;;=4^N06.9
 ;;^UTILITY(U,$J,358.3,34072,2)
 ;;=^5015558
 ;;^UTILITY(U,$J,358.3,34073,0)
 ;;=N07.0^^154^1722^30
 ;;^UTILITY(U,$J,358.3,34073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34073,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ minor glomerular abnormality
 ;;^UTILITY(U,$J,358.3,34073,1,4,0)
 ;;=4^N07.0
 ;;^UTILITY(U,$J,358.3,34073,2)
 ;;=^5015559
 ;;^UTILITY(U,$J,358.3,34074,0)
 ;;=N07.1^^154^1722^29
 ;;^UTILITY(U,$J,358.3,34074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34074,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ focal & seg glomerular lesions
 ;;^UTILITY(U,$J,358.3,34074,1,4,0)
 ;;=4^N07.1
 ;;^UTILITY(U,$J,358.3,34074,2)
 ;;=^5015560
 ;;^UTILITY(U,$J,358.3,34075,0)
 ;;=N07.2^^154^1722^24
 ;;^UTILITY(U,$J,358.3,34075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34075,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse membranous glomrlneph
 ;;^UTILITY(U,$J,358.3,34075,1,4,0)
 ;;=4^N07.2
 ;;^UTILITY(U,$J,358.3,34075,2)
 ;;=^5015561
 ;;^UTILITY(U,$J,358.3,34076,0)
 ;;=N07.3^^154^1722^25
 ;;^UTILITY(U,$J,358.3,34076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34076,1,3,0)
 ;;=3^Hereditary nephropathy, NEC w/ diffuse mesangial prolif glomrlneph
